HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, July 21, 2022 (HealthDay News) -- The Biden administration announced Thursday that it will create a new division in the U.S. Department of Health and Human Services (HHS) focused solely on coordinating responses to pandemic threats and other health emergencies.
The office of the existing Assistant Secretary for Preparedness and Response (ASPR) will become its own operating division called the Administration for Strategic Preparedness and Response. This federal agency will be at the same level as the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration, The New York Times reported. Its role will include responsibility for oversight of the Strategic National Stockpile, which stores reserve medical supplies, and for contracting for and distributing vaccines in an emergency.
"This change allows ASPR to mobilize a coordinated national response more quickly and stably during future disasters and emergencies, while equipping us with greater hiring and contracting capabilities," Dawn O'Connell, the assistant secretary for preparedness and response, wrote to employees in an email Wednesday.
At the moment, the CDC, the FDA, and the U.S. National Institutes of Health manage different parts of the U.S. government's emergency response efforts to public health emergencies. And elevating the HHS division's role may create tensions among the agencies, The Times said.
Lawrence Gostin, a former CDC adviser who directs the O'Neill Institute for National and Global Health Law at Georgetown University in Washington, D.C., told The Times the announcement was vague, which he said was frustrating. "It's always tempting when an agency performs badly to sideline it or to designate its key functions to another agency, or to even defund it, which I think will happen as a consequence of this, when the right answer is to fix it," Gostin said. "Rather than raising the agency back to its days of pre-eminence, we've curbed it. I think the Biden administration and future administrations will rue the day that they clipped CDC's wings."
Still, CDC spokeswoman Kristen Nordlund told The Times that the agency "is supportive of assistant secretary O'Connell's vision for ASPR -- a critical partner for us in addressing public health threats. We will continue to work closely together to advance and protect the health of the American people."
The ASPR was put in charge of the national stockpile in 2018, a move opposed by the CDC at the time. When the pandemic started, the stockpile was short on ventilators, masks, and other basic supplies. O'Connell also already oversees the Biomedical Advanced Research and Development Authority, responsible for developing innovative vaccines and therapeutics. In the pandemic's early days, the assistant secretary running ASPR did not have the capability to contract with companies to purchase vaccines. The agency can now take over some of those responsibilities, which O'Connell said would be phased in "over a period of time."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on July 21, 2022